VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $18,439,854 | +55.3% | 728,560 | +18.3% | 0.00% | +33.3% |
Q3 2022 | $11,873,916 | -22.1% | 615,867 | +2.9% | 0.00% | -25.0% |
Q2 2022 | $15,240,331 | +7.1% | 598,364 | +8.2% | 0.00% | +33.3% |
Q1 2022 | $14,226,169 | -31.7% | 553,117 | +11.2% | 0.00% | -25.0% |
Q4 2021 | $20,827,000 | +21.6% | 497,420 | +26.4% | 0.00% | 0.0% |
Q3 2021 | $17,132,000 | +24.2% | 393,669 | +35.0% | 0.00% | +33.3% |
Q2 2021 | $13,790,000 | -46.8% | 291,675 | -42.3% | 0.00% | -50.0% |
Q1 2021 | $25,918,000 | +69.4% | 505,527 | -11.5% | 0.01% | +50.0% |
Q4 2020 | $15,298,000 | -30.3% | 571,244 | -10.7% | 0.00% | -33.3% |
Q3 2020 | $21,948,000 | -34.1% | 639,338 | -21.4% | 0.01% | -40.0% |
Q2 2020 | $33,305,000 | +10506.7% | 812,916 | +3151.7% | 0.01% | – |
Q4 2019 | $314,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |